Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
---|
CEO | Ms. Laura A. Francis MBA |
IPO Date | Oct. 17, 2018 |
Location | United States |
Headquarters | 471 El Camino Real |
Employees | 344 |
Sector | Health Care |
Industries |
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Past 5 years
USD 17.51
USD 11.84
USD 3.15
USD 18.24
USD 67.79
USD 57.52
USD 17.46
USD 33.15
USD 138.83
USD 23.55
USD 30.08
USD 8.01
USD 6.84
StockViz Staff
January 15, 2025
Any question? Send us an email